Latest Licensing News

Breakthrough Minerals has resolved a critical regulatory issue allowing the Errolls Gold Project acquisition to proceed, with drilling set to begin next quarter targeting high-grade gold extensions.

Avecho Biotechnology has expanded its pivotal Phase III clinical trial for a CBD insomnia treatment by adding new recruitment sites and partnering with pharmaceutical giant Sandoz to boost patient enrolment and regulatory progress.

Kingston Resources has agreed to sell its Misima Gold Project to Ok Tedi Mining for $95 million, strengthening its balance sheet and enabling a strategic pivot towards expanding its Mineral Hill copper and gold operations.

Newfield Resources has taken a significant step forward with a new management partnership for its Tongo Diamond Mine, while facing legal challenges over the termination of its Tonguma Mine agreement.

Lindian Resources has assured investors that its bauxite projects in Guinea remain untouched by recent government mining license cancellations, underscoring stable progress despite regulatory upheaval.

Asara Resources reveals a robust 923,000-ounce gold resource at its Kada Project in Guinea’s prolific Siguiri Basin, setting the stage for extensive drilling and expansion in 2025.

Anatara Lifesciences has expanded its intellectual property footprint with a 20-year patent granted in Hong Kong for its GaRP gastrointestinal health product, following similar approvals in Europe and Australia. This milestone strengthens its commercial position in the lucrative global market for digestive health solutions.

Manhattan Corporation Limited (ASX: MHC) unveils strategic advances across its high-grade gold, lithium, and uranium projects, highlighted by a farm-in joint venture with Novo Resources and key management appointments.

Besra Gold has appointed David Potter as Chair and Sean Williamson as Director, bolstering its board with seasoned expertise as it transitions from exploration to gold production at the Jugan Project.

Cynata Therapeutics confirms that the recent FDA orphan-drug exclusivity granted to Ryoncil® will not block approval of its CYP-001 therapy, highlighting key differences in drug composition and patient indications.

ECS Botanics is on track for a record-breaking FY25 harvest with a 50% production increase and new premium product launches, signaling strong growth and a positive cash flow outlook.

The Finnish Government’s proposed amendments to the Mining Act could resolve licensing uncertainties for Latitude 66’s KSB Project, even as key mining rights expire following a court decision.